ACME Laboratories (DHA:ACMELAB) EPS (Basic): BDT9.41 (TTM As of Mar. 2026)


DHA:ACMELAB ACME Laboratories Ltd DHA:ACMELAB
82 GF Score
Price BDT81.30
GF Value BDT124.70
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is ACME Laboratories EPS (Basic)?

ACME Laboratories DHA:ACMELAB +0.37% 82 EPS (Basic) is BDT9.41 as of Mar. 2026. GuruFocus rates DHA:ACMELAB with a GF Score™ of 82/100 and a GF Value™ of BDT124.70 (Possible Value Trap). The stock has 7 warning signs investors should review.

ACME Laboratories's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was BDT3.30. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was BDT9.41.

ACME Laboratories's EPS (Diluted) for the three months ended in Mar. 2026 was BDT3.30. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was BDT9.41.

ACME Laboratories's EPS without NRI for the three months ended in Mar. 2026 was BDT3.30. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 9.41.

During the past 12 months, ACME Laboratories's average EPS without NRIGrowth Rate was 8.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 16.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, ACME Laboratories's highest 3-Year average EPS without NRI Growth Rate was 16.70% per year. The lowest was -0.10% per year. And the median was 13.70% per year.

ACME Laboratories  (DHA:ACMELAB) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

ACME Laboratories EPS (Basic) Related Terms

ACME Laboratories EPS (Basic) Historical Data

* Premium members only.

The historical data trend for ACME Laboratories's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACME Laboratories EPS (Basic) Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only 6.85 7.42 9.98 10.89 11.61

ACME Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.86 2.81 3.01 3.10 3.30
DHA:ACMELAB
82GF Score
ACME Laboratories Ltd DHA:ACMELAB
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ACME Laboratories EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

ACME Laboratories's Basic EPS for the fiscal year that ended in Jun. 2024 is calculated as

Basic EPS (A: Jun. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(2456.181-0)/211.602
=11.61

ACME Laboratories's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(697.892-0)/211.482
=3.30

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT9.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of BDT9.41 mean?
ACME Laboratories (DHA:ACMELAB) has a EPS (Basic) of BDT9.41 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on ACME Laboratories and its competitors.
Is ACME Laboratories' EPS (Basic) too high?
ACME Laboratories' current EPS (Basic) is BDT9.41. Overall, ACME Laboratories has a GF Score™ of 82/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ACME Laboratories' EPS (Basic) compare to ZTS and UTHR?
ACME Laboratories' EPS (Basic) of BDT9.41 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on ACME Laboratories and its competitors. ACME Laboratories's current EPS (Basic) is BDT9.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACME Laboratories stock overvalued right now?
Based on GuruFocus' analysis, ACME Laboratories (DHA:ACMELAB) is currently considered Possible Value Trap. The stock's GF Value™ is BDT124.70, compared to a current price of BDT81.30 — trading 34.8% below its estimated fair value. The current EPS (Basic) is BDT9.41. ACME Laboratories' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For ACME Laboratories (DHA:ACMELAB), the current EPS (Basic) is BDT9.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ACME Laboratories (DHA:ACMELAB) Overvalued in 2026?

Based on GuruFocus' analysis, ACME Laboratories stock appears to be undervalued. The current stock price of BDT81.30 is trading 34.8% below its estimated GF Value™ of BDT124.70. GuruFocus considers ACME Laboratories to be Possible Value Trap.

Key valuation signals for DHA:ACMELAB:

  • EPS (Basic): BDT9.41
  • GF Value™: BDT124.70 vs. price of BDT81.30 (34.8% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the DHA:ACMELAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ACME Laboratories Business Description

Address 1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, sachet products; veterinary drugs comprising dosages form like bolus, liquid,injection, water-soluble powder, premix and herbal drugs comprising dosages form like liquid, capsule, tablet, cream. The products of the company are sold in domestic and international markets.
82GF Score

Get the complete analysis for DHA:ACMELAB

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT81.30
Price
BDT124.70
GF Value